{"article_title": "Avista&#8217;s Vertitcal/Trigen, Owner of Nexa, Merges with Osmotica", "article_keywords": ["pharmaceutical", "representaciones", "trigen", "vertical", "generic", "merges", "vertitcaltrigen", "verticaltrigen", "drug", "pharmaceuticals", "health", "owner", "avista8217s", "osmotica", "company", "nexa"], "article_url": "http://www.themiddlemarket.com/news/healthcare/avistas-vertitcaltrigen-owner-of-nexa-merges-with-osmotica-259177-1.html", "article_text": "Avista\u2019s Vertitcal/Trigen, Owner of Nexa, Merges with Osmotica\n\nOther recent generic drug deals include the purchases of Harvard Drug and Representaciones e Investigaciones\n\nPharmaceutical company Vertical/Trigen Holdings LLC, backed by Avista Capital Partners, has agreed to merge with Osmotica Holdings Corp. for an undisclosed amount.\n\nVertical/Trigen is the parent company of Vertical Pharmaceuticals and Trigen Laboratories. Vertical, based in Sayreville, New Jersey, is known for its Nexa and OB Complete women\u2019s health, Corvite vitamin supplements, and Lorzone pain management brands. Trigen is the company\u2019s generic drugs division. Avista acquired a majority stake in Vertical/Trigen in 2013 when it invested alongside management.\n\nOsmotica, located in Marietta, Georgia, is a pharmaceutical company that focuses on treating movement disorders, such as Parkinson\u2019s disease. The combined company will have Osmotica's name and will be jointly owned by Vertical/Trigen and Osmotica.\n\nAvista is a middle-market private equity firm that focuses mostly on the health care, energy and communication sectors. The firm has offices in New York, Houston and London.\n\nBuyer interest for generic drug distributors has been picking up lately. Cardinal Health Inc. is adding Harvard Drug Group; Cipla Ltd. (NSE: CIPLA) is buying InvaGen Pharmaceuticals Inc. and Exelan Pharmaceuticals Inc.; and Teva Pharmaceutical Industries Ltd. (TLV: TLVA) is purchasing Representaciones e Investigaciones M\u00e9dicas SA.\n\nJefferies LLC and Covington & Burling LLP are advising Osmotica. Weil Gotshal & Manges LLP is representing Vertical/Trigen.\n\nFor more information on related topics, visit the following:", "article_metadata": {"og": {"url": "http://www.themiddlemarket.com/news/healthcare/avistas-vertitcaltrigen-owner-of-nexa-merges-with-osmotica-259177-1.html", "image": "http://cdn.themiddlemarket.com/media/newspics/nexa.jpeg", "site_name": "Mergers & Acquisitions, Latest News", "title": "Avista\u2019s Vertitcal/Trigen, Owner of Nexa, Merges with Osmotica"}}, "article_summary": "Osmotica, located in Marietta, Georgia, is a pharmaceutical company that focuses on treating movement disorders, such as Parkinson\u2019s disease.\nAvista\u2019s Vertitcal/Trigen, Owner of Nexa, Merges with OsmoticaOther recent generic drug deals include the purchases of Harvard Drug and Representaciones e InvestigacionesPharmaceutical company Vertical/Trigen Holdings LLC, backed by Avista Capital Partners, has agreed to merge with Osmotica Holdings Corp. for an undisclosed amount.\nBuyer interest for generic drug distributors has been picking up lately.\nVertical/Trigen is the parent company of Vertical Pharmaceuticals and Trigen Laboratories.\nVertical, based in Sayreville, New Jersey, is known for its Nexa and OB Complete women\u2019s health, Corvite vitamin supplements, and Lorzone pain management brands."}